The Union health ministry has issued draft rules to mandate a blue vertical strip on all antimicrobial drug labels, aiming to rein in over-the-counter misuse and tackle India's growing antimicrobial resistance (AMR) problem.
The Union health ministry has banned the manufacture, sale and distribution of all oral formulations containing the popular painkiller nimesulide above 100 milligrams for human use, citing health risks.
Drug regulator DCGI has asked drug controllers of all states and Union Territories to direct manufacturers under their jurisdiction to monitor the presence of a potentially carcinogenic chemical -- N-Nitrosodimethylamine -- in antacid Ranitidine.
At present, there is no provision under Drugs Rules, 1945 to address issues of wrong information to obtain regulatory approvals.
FDC drugs are those which contain a combination of two or more active pharmaceutical ingredients in a fixed ratio and are also referred to as 'cocktail' drugs.
A large number of medical device-manufacturing units have been forced to move to Vietnam and Malaysia due to delays, inconsistent timelines, and a lack of transparency in licensing processes, according to the Parliamentary Standing Committee on Health and Family Welfare.
rediffGURU Nayagam PP advises young aspirants how to pick the right course and career.
.jpg)
The Drugs Controller General of India is considering the recommendations of its advisory body to revoke the suspension of the sale of analgin-based medicines in the country.
The original list had named 349 drugs, but 15 drugs, approved prior to 1988, have been kept outside the purview of the ban
The change in labelling, which is seen as a part of government's effort to push generic drugs, will come into effect from September 13.
Besides opposing the suspension of three medicines, the sector has also questioned the process adopted by the government.
The new regime aims to bring in ease of doing business, as the NITI Aayog has proposed to do away with the need to have manufacturing licences to register medical devices or to get a certificate of compliance.
Experts believe the move will have little impact given limited production of generic drugs and authority of doctors in prescribing medicines.
Industry is gathering scientific data to approach the regulator, DCGI, for a review of the suspension order.
The Delhi high court had earlier allowed Indian pharma major Wockhardt to sell its Ace Proxyvon tablets, which is a mixture of three salts -- aceclofenac, paracetamol and rabeprazol -- a combination that is banned.
Some of the popular brands that would be impacted include Phensedyl (Abbott), Tixylix (Abbott), Gluconorm PG (Lupin), Ascoril D (Glenmark), Solvin Cold (Ipca), D Cold Total (Paras Pharma).
Dr Ganesh Natarajan, a special guest on rediffGURUS, has been addressing questions from Rediff readers, about how to grow professionally, how women can achieve leadership roles in Indian companies, and what it takes to succeed as an entrepreneur.
Codeine-based formulations are under the scanner for misuse as a narcotic product.
Roadblocks ahead as these medicines could face new clinical tests, more scrutiny
Popular antacid Mucaine Gel, manufactured by Pfizer's subsidiary Wyeth Laboratories, was also found laced with the heavy metals as well as cadmium.
After recognising its adverse health effects, the govt has now dismissed its own lab reports to conclude that the evidence against plastic is insufficient.
E-cigarettes pose a huge health risk to users, who more often than not are adolescents and young adults
rediffGURU Mayank Chandel offers advice to students interested in a careers in science or engineering after class 10 and 12.
Responding to another question, Choubey said that the phase-I of clinical trials have revealed excellent safety of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd, and now their immunogenicity testing is in progress. Their phase II clinical trials are ongoing.
Her appointment as World Health Organisation's deputy director offers an opportunity to push for improving the medical research environment in India.
There is a high demand for IT professionals who can envision, design and develop applications for the future.
'We cannot be naughty and expect the government to do good!' 'We have to behave ourselves and then we can expect the government to support us.' 'If we are able to protect ourselves well, then we should not be having deaths.' 'Unfortunately, people have gotten into this super scary event participation (mode) -- birthday parties, large gatherings.' 'Among the people who have attended those, 80 to 90 per cent of them have come down with COVID-19.'
Bank shares were the top gainer in early trades with Bank of Baroda up over 4%.
India has so far succeeded in staving off the deadly virus that has claimed over 4,500 lives abroad.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances